ArticleJournal of translational medicine2021

Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment.

Lydia Ntari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.